Mark Boguniewicz

Jul 16, 2023 | onlinelibrary.wiley.com | Eric Simpson |Emma Guttman-Yassky |Lawrence Eichenfield |Mark Boguniewicz

Pivotal phase 3 clinical trials of tralokinumab in adult AD The phase 3 clinical trials in adults, ECZTRA 1/2 (monotherapy),22 and ECZTRA 3 (combination with topical corticosteroids [TCS] as needed)21 are summarized in Figure 2 and Table 1. Overview of study design and inclusion criteria for pivotal phase 3 tralokinumab clinical trials: ECZTRA 1, 2, and 3.